| scholarly article | Q13442814 |
| P2093 | author name string | Caen JP | |
| Bikfalvi A | |||
| Savona C | |||
| Han ZC | |||
| Perollet C | |||
| P433 | issue | 9 | |
| P304 | page(s) | 3289-3299 | |
| P577 | publication date | 1998-05-01 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | Platelet factor 4 modulates fibroblast growth factor 2 (FGF-2) activity and inhibits FGF-2 dimerization | |
| P478 | volume | 91 |
| Q24303828 | An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4 |
| Q54969912 | Angiodrastic Chemokines in Colorectal Cancer: Clinicopathological Correlations. |
| Q36166483 | Angiogenesis inhibitors found within the haemostasis pathway. |
| Q30428793 | Angiostatic and chemotactic activities of the CXC chemokine CXCL4L1 (platelet factor-4 variant) are mediated by CXCR3. |
| Q34391833 | Angiostatic factors in the pulmonary endarterectomy material from chronic thromboembolic pulmonary hypertension patients cause endothelial dysfunction |
| Q34786603 | Angiostatic, tumor inflammatory and anti-tumor effects of CXCL4(47-70) and CXCL4L1(47-70) in an EGF-dependent breast cancer model |
| Q26866276 | Anti-angiogenic gene therapy in the treatment of malignant gliomas |
| Q30432791 | CXC chemokines in cancer angiogenesis and metastases |
| Q47559793 | Cellular and Molecular Changes in MNU-Induced Breast Tumours Injected with PF4 or bFGF |
| Q93001507 | Chemokines and their Receptors: Multifaceted Roles in Cancer Progression and Potential Value as Cancer Prognostic Markers |
| Q30426904 | Chemokines as mediators of angiogenesis. |
| Q30438032 | Chemokines as mediators of neovascularization |
| Q30427886 | Chemokines as mediators of tumor angiogenesis and neovascularization |
| Q86199528 | Chemokines in cancer |
| Q34317591 | Dimerization capacities of FGF2 purified with or without heparin-affinity chromatography |
| Q90381865 | Effective Treatments for Bladder Cancer Affecting CXCL9/CXCL10/CXCL11/CXCR3 Axis: A Review |
| Q37997765 | Exploiting Surface Plasmon Resonance (SPR) Technology for the Identification of Fibroblast Growth Factor-2 (FGF2) Antagonists Endowed with Antiangiogenic Activity. |
| Q92403252 | Exploring the Extracellular Regulation of the Tumor Angiogenic Interaction Network Using a Systems Biology Model |
| Q36129961 | Impaired CXCL4 expression in tumor-associated macrophages (TAMs) of ovarian cancers arising in endometriosis |
| Q36019493 | Knockdown of aberrantly expressed nuclear localized decorin attenuates tumour angiogenesis related mediators in oral cancer progression model in vitro. |
| Q57817458 | Long Pentraxin-3 Modulates the Angiogenic Activity of Fibroblast Growth Factor-2 |
| Q61809077 | Lymph Node Lymphatic Endothelial Cell Expansion and Contraction and the Programming of the Immune Response |
| Q28079232 | Molecular and clinical significance of fibroblast growth factor 2 (FGF2 /bFGF) in malignancies of solid and hematological cancers for personalized therapies |
| Q37017056 | Ovarian cancer stroma: pathophysiology and the roles in cancer development |
| Q37487079 | Platelet alpha-granules: basic biology and clinical correlates |
| Q33938595 | Platelet factor-4 and its p17-70 peptide inhibit myeloma proliferation and angiogenesis in vivo |
| Q37705023 | Platelet-derived chemokines: pathophysiology and therapeutic aspects |
| Q28587821 | Prox1 promotes lineage-specific expression of fibroblast growth factor (FGF) receptor-3 in lymphatic endothelium: a role for FGF signaling in lymphangiogenesis |
| Q36960001 | Role of platelet chemokines, PF-4 and CTAP-III, in cancer biology. |
| Q35910187 | Seasonal Changes in Testes Vascularisation in the Domestic Cat (Felis domesticus): Evaluation of Microvasculature, Angiogenic Activity, and Endothelial Cell Expression |
| Q30441368 | The CXC-chemokine CXCL4 interacts with integrins implicated in angiogenesis |
| Q57812382 | The Role of Chemokines in Wound Healing |
| Q34425462 | The hemostatic system and angiogenesis in malignancy. |
| Q38023245 | The role of CXC chemokines and their receptors in the progression and treatment of tumors |
| Q37863514 | The role of chemokines and their receptors in angiogenesis |
| Q59941220 | Type 1 IFN and PD-L1 Coordinate Lymphatic Endothelial Cell Expansion and Contraction during an Inflammatory Immune Response |
| Q35157184 | Vascular normalization induced by sinomenine hydrochloride results in suppressed mammary tumor growth and metastasis |
Search more.